ArticleChest2022

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.

Sanne Maria Henriette Zweijpfenning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.